Valuation: genedrive plc

Market Cap 20.87M 27.86M 24.36M 22.38M 39.56M 2.65B 40.15M 269M 104M 1.3B 105M 102M 4.5B P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 19.69M 26.28M 22.98M 21.11M 37.32M 2.5B 37.88M 254M 98.56M 1.23B 98.6M 96.51M 4.24B EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
36.5%
Yield 2024 *
-
Yield 2025 -
3 months+36.84%
6 months+48.57%
Current year+48.57%
1 week 1.25
Extreme 1.25
1.5
1 month 1.15
Extreme 1.15
1.5
Current year 0.75
Extreme 0.75
1.5
1 year 0.19
Extreme 0.19
1.5
3 years 0.19
Extreme 0.19
18
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 05/08/2024
Director of Finance/CFO 48 06/04/2022
Director TitleAgeSince
Director/Board Member 69 08/04/2018
Director/Board Member 52 21/08/2018
Director/Board Member 56 10/09/2023
Date Insider Type Main position Quantity % Market Cap.
19/12/24Free

Chief Executive Officer

3,500,000 0.6444%
19/12/24Buy

Chief Executive Officer

1,135,208 0.2090%
19/12/24Buy

Chairman

225,000 0.0414%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-7.14%-92.57% 27.89M
-1.95%-1.56%+1.21%-28.54% 16.67B
+5.89%+17.22%+43.79%+99.43% 1.68B
+0.39%+34.99%-39.53%-77.97% 1.24B
+0.06%+3.18%-28.32%+31.12% 1.14B
+1.31%-0.09%-25.81%-52.92% 631M
+0.21%-0.98%-39.13%-56.82% 580M
-0.66%+3.11%+21.67%-54.99% 447M
+1.79%-1.42%-55.45%-60.47% 375M
+2.52%+5.48%-20.26%-20.26% 353M
Average +0.96%+5.90%-14.90%-31.40% 2.32B
Weighted average by Cap. -0.86%+3.68%-1.94%-21.31%

Financials

2024 2025
Net sales 501K 669K 585K 537K 950K 63.66M 964K 6.45M 2.51M 31.28M 2.51M 2.46M 108M 954K 1.27M 1.11M 1.02M 1.81M 121M 1.84M 12.28M 4.78M 59.56M 4.78M 4.68M 206M
Net income -7.08M -9.44M -8.26M -7.58M -13.41M -899M -13.61M -91.11M -35.41M -442M -35.43M -34.68M -1.52B -5.23M -6.98M -6.1M -5.61M -9.91M -665M -10.06M -67.36M -26.18M -327M -26.19M -25.64M -1.13B
Net Debt -5.17M -6.9M -6.03M -5.54M -9.8M -657M -9.94M -66.56M -25.87M -323M -25.88M -25.34M -1.11B -1.18M -1.58M -1.38M -1.27M -2.24M -150M -2.27M -15.22M -5.92M -73.79M -5.92M -5.79M -255M
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
03/07/26 GBX 1.300 0.00% 2,357,189
02/07/26 GBX 1.300 0.00% 130,231
01/07/26 GBX 1.300 0.00% 805,760
30/06/26 GBX 1.300 0.00% 3,309,027
29/06/26 GBX 1.300 0.00% 13,575,014

Annual profits - Rate of surprise